High penetrance and pronounced variation in expressivity of GCH1 mutations in five families with dopa‐responsive dystonia

We performed a clinical and molecular genetic analysis in members of five families with dopa‐responsive dystonia. Four mutations were detected in the gene GCH1 that codes for GTP cyclohydrolase I. Two of these mutations, a delG309 in exon I and a C544T transition in exon 5, have not been described before. They result in inactivation of the enzyme by truncation. The remaining two mutations, both A to G transitions, a(−2)g in intron I and a(−2)g in intron 2, cause truncation by abnormal splicing. The genotype of family members was correlated to their clinical phenotype (obtained before molecular analysis). Clinical symptoms observed in the families included generalized and focal dystonia, abnormal gait, and subtle signs such as an abnormal writing test. High penetrance (0.8–1.0) was observed in four of five families if minor symptoms and signs were considered. A given mutation was more likely to cause symptoms in females than in males, thus confirming the well‐established higher incidence of dopa‐responsive dystonia in females than in males.

[1]  T. Nygaard,et al.  Dopa-responsive dystonia : delineation of the clinical syndrome and clues to pathogenesis , 1993 .

[2]  M. Segawa Hereditary progressive dystonia with marked diurnal fluctuation , 2000, Brain and Development.

[3]  G. K. Smith,et al.  Biosynthesis and metabolism of tetrahydrobiopterin and molybdopterin. , 1985, Annual review of biochemistry.

[4]  S. Tsuji,et al.  Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene , 1994, Nature Genetics.

[5]  S. Kish,et al.  Dopa-responsive Dystonia , 2004 .

[6]  T. Sekiya,et al.  Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[7]  E. Bebin,et al.  Oral phenylalanine loading in dopa‐responsive dystonia , 1997, Neurology.

[8]  S. Fahn,et al.  Dopa‐responsive dystonia , 1990, Neurology.

[9]  S. Udenfriend,et al.  Conversion of L-tyrosine to 3,4-dihydroxyphenylalanine by cell-free preparations of brain and sympathetically innervated tissues. , 1964, Biochemical and biophysical research communications.

[10]  G. Deuschl,et al.  Two previously unrecognized splicing mutations of GCH1 in Dopa-responsive dystonia: exon skipping and one base insertion , 1997, Neurogenetics.

[11]  R. de la Fuente-Fernández,et al.  A novel point mutation in the GTP cyclohydrolase I gene in a Spanish family with hereditary progressive and dopa responsive dystonia. , 1997, Journal of neurology, neurosurgery, and psychiatry.

[12]  N. Blau,et al.  Characterization of Mouse and Human GTP Cyclohydrolase I Genes , 1995, The Journal of Biological Chemistry.

[13]  S. Tsuji,et al.  GTP cyclohydrolase I gene in hereditary progressive dystonia with marked diurnal fluctuation , 1995, Neuroscience Letters.

[14]  C. Marsden,et al.  Dopa-responsive dystonia in British patients: new mutations of the GTP-cyclohydrolase I gene and evidence for genetic heterogeneity. , 1996, Human molecular genetics.

[15]  F. Wooten,et al.  Dopa-responsive dystonia , 1998, Neurology.

[16]  C. Heizmann,et al.  A missense mutation in a patient with guanosine triphosphate cyclohydrolase I deficiency missed in the newborn screening program. , 1995, The Journal of pediatrics.

[17]  H. Ito,et al.  Exon skipping caused by a base substitution at a splice site in the GTP cyclohydrolase I gene in a Japanese family with hereditary progressive dystonia dopa responsive dystonia. , 1995, Biochemical and biophysical research communications.